<font color="red">Salmeterol_2</font> <font color="red">plus_2</font> <font color="red">fluticasone_2</font> <font color="red">propionate_2</font> versus <font color="red">fluticasone_2</font> <font color="red">propionate_2</font> <font color="red">plus_2</font> <font color="red">montelukast_2</font> <font color="red">:_2</font> a randomised controlled trial investigating the effects on airway inflammation in asthma . 
<br>
<br> BACKGROUND Few studies have compared treatment strategies in patients with asthma poorly controlled on low dose inhaled corticosteroids , and little is known about the effects of different treatments on airway inflammation . In this double - blind , <font color="red">placebo_1</font> <font color="red">-_1</font> controlled , parallel group study , we compared the effects of <font color="red">salmeterol_2</font> <font color="red">plus_2</font> <font color="red">fluticasone_2</font> <font color="red">propionate_2</font> <font color="red">(_2</font> <font color="red">FP_2</font> <font color="red">)_2</font> <font color="red">(_2</font> <font color="red">Seretide_2</font> <font color="red">;_2</font> <font color="red">SFC_2</font> <font color="red">)_2</font> and <font color="red">FP_2</font> <font color="red">plus_2</font> <font color="red">montelukast_2</font> <font color="red">(_2</font> <font color="red">FP_2</font> <font color="red">/_2</font> <font color="red">M_2</font> <font color="red">)_2</font> on sputum inflammatory markers , airway responsiveness , lung function , and symptoms in adult asthmatics . 
<br> METHODS Sixty - six subjects were randomised to <font color="red">SFC_2</font> or <font color="red">FP_2</font> <font color="red">/_2</font> <font color="red">M_2</font> for 12 weeks . The primary outcome was changes in neutrophil , eosinophil , macrophage , lymphocyte , and epithelial cell levels in induced sputum . Additional outcomes included the change in other sputum markers of airway inflammation , airway responsiveness , symptom control , and lung function . 
<br> RESULTS Both treatments had no significant effect on induced sputum inflammatory cells , although there was a trend for a reduction in sputum eosinophils . Both treatments significantly improved airway responsiveness , whereas <font color="red">SFC_2</font> generally led to greater improvements in symptom control and lung function than <font color="red">FP_2</font> <font color="red">/_2</font> <font color="red">M._2</font> <font color="red">FP_2</font> <font color="red">/_2</font> <font color="red">M_2</font> led to significantly greater reductions in sputum cysteinyl leukotrienes than <font color="red">SFC_2</font> ( treatment ratio 1.80 ; 95% CI 1.09 , 2.94 ) . 
<br> CONCLUSION <font color="red">Both_1</font> <font color="red">treatments_1</font> led to similar control of eosinophilic airway inflammation , although PEF and symptom control were better with <font color="red">SFC_2</font> <font color="red">._2</font> STUDY NUMBER : SAM40030 ( SOLTA ) .